Novo Nordisk A/S (MEX:NVO) Transcripts
Q1 2024 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
4 days ago
MXN2146.29
(+1.36%)
Earnings
Q1 2024 Novo Nordisk A/S Earnings Call Transcript
5 days ago
MXN2117.5
(-4.93%)
Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
Mar 21, 2024
Novo Nordisk A/S Capital Markets Day Transcript
Mar 07, 2024
Q4 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Feb 01, 2024
MXN1981.1
(-1.44%)
Earnings
Q4 2023 Novo Nordisk A/S Earnings Call Transcript
Jan 31, 2024
MXN2009.99
(+7.91%)
Earnings
Novo Nordisk A/S at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Novo Nordisk A/S at American Heart Association Conference Transcript
Nov 11, 2023
Q3 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Nov 03, 2023
MXN1748.39
(+0.19%)
Earnings
Q3 2023 Novo Nordisk A/S Earnings Call Transcript
Nov 02, 2023
MXN1745.07
Earnings
Q2 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Aug 11, 2023
MXN1544.95
(-3.74%)
Earnings
Q2 2023 Novo Nordisk A/S Earnings Call Transcript
Aug 10, 2023
MXN1605
Earnings
Novo Nordisk A/S R&D Investor Call Transcript
Jun 26, 2023
Q1 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
May 09, 2023
MXN1489
(+2.34%)
Earnings
Q1 2023 Novo Nordisk A/S Earnings Call Transcript
May 04, 2023
MXN1430.5
(-4.60%)
Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
Mar 23, 2023
Q4 2022 Novo Nordisk A/S Earnings Call Transcript
Feb 01, 2023
MXN1299.5
Earnings
Q3 2022 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Nov 03, 2022
MXN1128.4
(+7.47%)
Earnings
Q3 2022 Novo Nordisk A/S Earnings Call Transcript
Nov 02, 2022
MXN1050
Earnings
Novo Nordisk A/S at JPMorgan CEO Call Series Transcript
Sep 14, 2022
Q2 2022 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Aug 05, 2022
MXN1062.5
(+2.19%)
Earnings
Q2 2022 Novo Nordisk A/S Earnings Call Transcript
Aug 03, 2022
MXN1039.68
(-12.53%)
Earnings
Novo Nordisk A/S Investor and Analyst Event at ADA Transcript
Jun 06, 2022
Q1 2022 Novo Nordisk A/S Earnings Presentation - London Transcript
May 05, 2022
Q1 2022 Novo Nordisk A/S Earnings Call Transcript
Apr 29, 2022
MXN1174
(+3.63%)
Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
Mar 24, 2022
Novo Nordisk A/S Capital Markets Day Transcript
Mar 03, 2022
Q4 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Feb 04, 2022
MXN1037
(+1.32%)
Earnings
Q4 2021 Novo Nordisk A/S Earnings Call Transcript
Feb 02, 2022
MXN1023.5
Earnings
Novo Nordisk A/S to Discuss Supply Challenges for Wegovy Call Transcript
Dec 20, 2021
Q3 2021 Novo Nordisk A/S Earnings Presentation (London-Based Investors) Transcript
Nov 04, 2021
Q3 2021 Novo Nordisk A/S Earnings Call Transcript
Nov 03, 2021
MXN1193.5
(+4.46%)
Earnings
Q2 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Aug 06, 2021
MXN975.81
(-5.83%)
Earnings
Q2 2021 Novo Nordisk A/S Earnings Call Transcript
Aug 04, 2021
MXN906.5
Earnings
Novo Nordisk A/S R&D Investor Call Transcript
Jun 28, 2021
Novo Nordisk A/S Approval of Wegovy™ in the United States Investor Call Transcript
Jun 07, 2021
Novo Nordisk A/S to Discuss International Operations Call Transcript
May 21, 2021
Q1 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
May 06, 2021
MXN750.28
Earnings
Q1 2021 Novo Nordisk A/S Earnings Call Transcript
May 05, 2021
MXN750.28
(-1.17%)
Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
Mar 25, 2021
Q4 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Feb 05, 2021
MXN700.13
Earnings
Q4 2020 Novo Nordisk A/S Earnings Call Transcript
Feb 03, 2021
MXN700.13
Earnings
Novo Nordisk A/S at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Novo Nordisk A/S to Announce the Decision to Enter the Phase 3 Development in Alzheimer's Disease with Oral Semaglutide Call Transcript
Dec 16, 2020
Novo Nordisk A/S ESG Conference Call Transcript
Nov 30, 2020
Q3 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Nov 02, 2020
MXN685.5
Earnings
Q3 2020 Novo Nordisk A/S Earnings Call Transcript
Oct 30, 2020
MXN685.5
(-3.81%)
Earnings
Novo Nordisk A/S to Discuss Updated 2020 Outlook Call Transcript
Oct 09, 2020
Q2 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Aug 07, 2020
MXN733.59
(-4.70%)
Earnings
Q2 2020 Novo Nordisk A/S Earnings Call Transcript
Aug 06, 2020
MXN769.8
Earnings
Novo Nordisk A/S Virtual R&D Investor Call (Q&A) Transcript
Jun 19, 2020
Novo Nordisk A/S Virtual R&D Investor Presentation Transcript
Jun 19, 2020
Novo Nordisk A/S at UBS Global Healthcare Conference (Virtual) Transcript
May 20, 2020
Q1 2020 Novo Nordisk A/S Earnings Presentation Transcript
May 07, 2020
Q1 2020 Novo Nordisk A/S Earnings Call Transcript
May 06, 2020
MXN765
Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
Mar 26, 2020
Q4 2019 Novo Nordisk A/S Earnings Presentation Transcript
Feb 06, 2020
Q4 2019 Novo Nordisk A/S Earnings Call Transcript
Feb 05, 2020
MXN573.75
Earnings
Novo Nordisk A/S at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Novo Nordisk A/S Capital Markets Day Transcript
Nov 20, 2019
Dicerna Pharmaceuticals Inc to Discuss Collaboration with Novo Nordisk A/S Conference Call Transcript
Nov 18, 2019
Q3 2019 Novo Nordisk A/S Earnings Presentation Transcript
Nov 04, 2019
Q3 2019 Novo Nordisk A/S Earnings Call Transcript
Nov 01, 2019
MXN528.24
Earnings
Novo Nordisk A/S to Discuss Rybelsus® US Approval Call Transcript
Sep 23, 2019
Q2 2019 Novo Nordisk A/S Earnings Presentation Transcript
Aug 12, 2019
Q2 2019 Novo Nordisk A/S Earnings Call Transcript
Aug 09, 2019
MXN487
(+2.06%)
Earnings
Novo Nordisk A/S Investor and Analyst Event at ADA 2019 Transcript
Jun 10, 2019
Q1 2019 Novo Nordisk A/S Earnings Presentation Transcript
May 07, 2019
Q1 2019 Novo Nordisk A/S Earnings Call Transcript
May 03, 2019
MXN451.01
(-3.31%)
Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
Mar 21, 2019